Hunan Er Kang Pharmaceutical Financial Flexibility Index
Hunan Er Kang Pharmaceutical financial flexibility index. Hunan Er Kang Pharmaceutical (300267) has a Financial Flexibility Index of 0.45x as of June 2023. Free cash flow of CN¥220.23 Million (operating CF CN¥174.55 Million minus capex CN¥45.68 Million) represents 0% of total liabilities (CN¥490.30 Million). See Hunan Er Kang Pharmaceutical (300267) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Hunan Er Kang Pharmaceutical (2008–2024)
Financial flexibility index of Hunan Er Kang Pharmaceutical from 2008 to 2024. Historical Financial Flexibility Index trend for Hunan Er Kang Pharmaceutical across 17 annual periods. Check 300267 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Hunan Er Kang Pharmaceutical Financial Flexibility Index by Year (2008–2024)
Hunan Er Kang Pharmaceutical financial flexibility index by year from 2008 to 2024. Year-by-year free cash flow to debt coverage for Hunan Er Kang Pharmaceutical. For the full cash flow conversion analysis, see 300267 operating cash flow.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.45x | CN¥362.29 Million | CN¥166.69 Million | CN¥797.54 Million | ▼ -21.4% |
| 2023 | 0.58x | CN¥386.61 Million | CN¥148.42 Million | CN¥669.05 Million | ▲ +2.3% |
| 2022 | 0.56x | CN¥454.51 Million | CN¥281.02 Million | CN¥804.57 Million | ▼ -28.7% |
| 2021 | 0.79x | CN¥442.02 Million | CN¥92.68 Million | CN¥558.28 Million | ▼ -24.0% |
| 2020 | 1.04x | CN¥784.42 Million | CN¥178.53 Million | CN¥753.22 Million | ▼ -54.9% |
| 2019 | 2.31x | CN¥810.03 Million | CN¥445.82 Million | CN¥350.72 Million | ▲ +328.6% |
| 2018 | 0.54x | CN¥220.62 Million | CN¥123.89 Million | CN¥409.39 Million | ▼ -82.5% |
| 2017 | 3.07x | CN¥948.03 Million | CN¥689.11 Million | CN¥308.37 Million | ▼ -23.0% |
| 2016 | 3.99x | CN¥1.63 Billion | CN¥486.50 Million | CN¥408.94 Million | ▲ +99.3% |
| 2015 | 2.00x | CN¥1.09 Billion | CN¥518.96 Million | CN¥544.10 Million | ▲ +54.6% |
| 2014 | 1.30x | CN¥702.81 Million | CN¥175.38 Million | CN¥542.64 Million | ▼ -61.3% |
| 2013 | 3.35x | CN¥378.20 Million | CN¥174.22 Million | CN¥113.01 Million | ▼ -22.2% |
| 2012 | 4.30x | CN¥315.31 Million | CN¥84.02 Million | CN¥73.32 Million | ▲ +137.0% |
| 2011 | 1.81x | CN¥119.59 Million | CN¥75.72 Million | CN¥65.90 Million | ▲ +101.1% |
| 2010 | 0.90x | CN¥107.52 Million | CN¥42.47 Million | CN¥119.15 Million | ▲ +129.2% |
| 2009 | 0.39x | CN¥29.82 Million | CN¥10.18 Million | CN¥75.72 Million | ▲ +82.2% |
| 2008 | 0.22x | CN¥12.83 Million | CN¥211.00K | CN¥59.37 Million | — |